No insider purchase over the last 90 days. The latest, by Hans Lennart Rudolf Wigzell, was filed 24 Jun 2020.
This page follows insider dealings at Karolinska Development AB as filed with Finansinspektionen. Nothing new has been filed by managers of Karolinska Development AB in twelve months, the latest record being from 24 June 2020.
Over the whole record (from 2017), the tally stands at 12 purchases and 7 sales.
These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
24 of 24 declarations
Karolinska Development AB is a Swedish company focused on the development of new therapies and medical technologies. It aims to create value from biomedical research in collaboration with academic institutions and businesses.